Influência da adição de plastificante do processo de reticulação na morfologia, absorção de aguá e propriedades mecânicas de filmes de alginato de sódio

The effects of sorbitol and formaldehyde on the morphology, water absorption and mechanical properties of sodium alginate films were analyzed. The morphology of the films indicated the presence of small aggregates in the surface of uncrosslinked films, which disappeared with the crosslinking process. The water uptake and percentage of elongation increased with the addition of sorbitol in uncrosslinked films. At the same time, a decrease in tensile strength and Young's modulus occurred. The swelling ratio and water uptake of crosslinked alginate/sorbitol films decreased with an increase in sorbitol content suggesting an enhanced crosslinking density due to the presence of plasticizer.

Congenital Heart Disease as a Warning Sign for the Diagnosis of the 22q11.2 Deletion

Background: To alert for the diagnosis of the 22q11.2 deletion syndrome (22q11.2DS) in patients with congenital heart disease (CHD). Objective: To describe the main CHDs, as well as phenotypic, metabolic and immunological findings in a series of 60 patients diagnosed with 22q11.2DS. Methods: The study included 60 patients with 22q11.2DS evaluated between 2007 and 2013 (M:F=1.3, age range 14 days to 20 years and 3 months) at a pediatric reference center for primary immunodeficiencies. The diagnosis was established by detection of the 22q11.2 microdeletion using FISH (n = 18) and/or MLPA (n = 42), in association with clinical and laboratory information. Associated CHDs, progression of phenotypic facial features, hypocalcemia and immunological changes were analyzed. Results: CHDs were detected in 77% of the patients and the most frequent type was tetralogy of Fallot (38.3%). Surgical correction of CHD was performed in 34 patients. Craniofacial dysmorphisms were detected in 41 patients: elongated face (60%) and/or elongated nose (53.3%), narrow palpebral fissure (50%), dysplastic, overfolded ears (48.3%), thin lips (41.6%), elongated fingers (38.3%) and short stature (36.6%). Hypocalcemia was detected in 64.2% and decreased parathyroid hormone (PTH) level in 25.9%. Decrease in total lymphocytes, CD4 and CD8 counts were present in 40%, 53.3% and 33.3%, respectively. Hypogammaglobulinemia was detected in one patient and decreased concentrations of immunoglobulin M (IgM) in two other patients. Conclusion: Suspicion for 22q11.2DS should be raised in all patients with CHD associated with hypocalcemia and/or facial dysmorphisms, considering that many of these changes may evolve with age. The 22q11.2 microdeletion should be confirmed by molecular testing in all patients.

Morbidade da esquistossomose no Brasil: IV. Evolução em pacientes tratados e seus controles

Um estudo comparativo sobre a evolução da morbidade da esquistossomose mansoni em pacientes tratados e não tratados em uma área endêmica, foi realizado após um e seis anos do tratamento inicial. No primeiro ano após o tratamento verificou-se uma drástica redução do número de ovos de S. mansoni por grama de fezes eliminadas pelos pacientes tratados em relação aos controles e também melhores condições clínicas dos pacientes tratados. Entretanto, ao final de seis anos de observação, embora o número de ovos de S. mansoni eliminados pelos pacientes tratados ainda fosse menor do que no grupo controle ele se aproximava do número inicial antes do tratamento. Em ambos os grupos houve evolução para formas clínicas mais graves, embora com uma certa tendência para maior gravidade no grupo controle. Recomenda-se que o tratamento da população em áreas endêmicas deva ser feito com intervalos de dois a três anos e não se dispensam medidas profiláticas como suprimento de aguá encanada nas casas e educação de base da população.